Furthermore, C9 and CsA potently suppressed the expression of integrin α6, CD133, CD44, ALDH1A1, Nanog, Oct4, and Sox2 in both NSCLC CSCs (Figure 5C,D). The gene discussed is CD44; the disease is non-small cell lung carcinoma.